Arctic Bioscience to Present at H.C. Wainwright Bioconnect Conference

Arctic Bioscience, a biotech company developing and commercializing nutraceutical and pharmaceutical products based on the unique properties of bioactive marine compounds, will present at the US investment bank H.C. Wainwright’s Bioconnect Virtual Conference – discussing the company's phase IIb clinical trial, 2021 accomplishments, long term-strategy and 2022 priorities.

H.C. Wainwright Bioconnect Conference Details:

Date: January 10^th from 13.00 CEST
Link: Arctic Bioscience company presentation

Full event details: H.C. Wainwright Bioconnect Conference

A recording of the presentation will be available on the company's website from Monday January 10^th at 13.30 CEST.